Lataa...
Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib Therapy
Multiple myeloma (MM) is a neoplasm of plasma cells within the bone marrow. A major impact on improving survival in MM has been the use of the boronic acid-derived proteasome inhibitor bortezomib, a first-in-class selective inhibitor of the 26S proteasome. Ocular side effects of bortezomib are rare....
Tallennettuna:
| Julkaisussa: | Hematol Rep |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
PAGEPress Publications, Pavia, Italy
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4508549/ https://ncbi.nlm.nih.gov/pubmed/26330998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2015.5729 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|